BrainStorm Cell Therapeutics
BCLI
#10402
Rank
S$8.58 M
Marketcap
S$0.78
Share price
0.00%
Change (1 day)
-63.28%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : S$11.18 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total liabilities are S$11.18 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

BrainStorm Cell Therapeutics - Total liabilities on balance sheet (from 2002 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$13.04 M8.94%
2023-12-31S$11.97 M-22.11%
2022-12-31S$15.37 M14.44%
2021-12-31S$13.43 M-35.72%
2020-12-31S$20.89 M-17.37%
2019-12-31S$25.28 M197.98%
2018-12-31S$8.48 M14.47%
2017-12-31S$7.41 M492.88%
2016-12-31S$1.25 M-70.05%
2015-12-31S$4.17 M-2.34%
2014-12-31S$4.27 M69.85%
2013-12-31S$2.51 M78.08%
2012-12-31S$1.41 M-13.09%
2011-12-31S$1.62 M-18.43%
2010-12-31S$1.99 M-43.19%
2009-12-31S$3.5 M-16.84%
2008-12-31S$4.22 M-16.47%
2007-12-31S$5.05 M29.77%
2006-12-31S$3.89 M
2006-03-31S$14.27 M4819.3%
2005-03-31S$0.29 M264.33%
2004-03-31S$0.07 M79.48%
2003-03-31S$0.04 M109.16%
2002-03-31S$0.02 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Gilead Sciences
GILD
S$48.08 B 429,877.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
S$2.53 B 22,603.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
S$1.40 B 12,469.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$14.26 B 127,465.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
S$0.66 B 5,869.60%๐Ÿ‡บ๐Ÿ‡ธ USA